Alex Gorsky formally became Johnson & Johnson’s CEO today, amid ongoing trouble with product recalls, manufacturing problems and government inquiries. Mr. Gorsky plans to rethink how the company develops new drugs and raise the bar on innovation, according to the report.
More Articles on Orthopedic Devices:
AlloSource Hires Dale Binke as Vice President of Marketing & Sales
Orthofix Sells Sports Medicine Business for $157.5M
Johnson & Johnson Q1 Orthopedic Sales Flat
Johnson & Johnson’s New CEO Speaks of Change
A new CEO has taken the reigns at Johnson & Johnson, and he plans major changes for the company, according to a New York Times report.
Shared risk, shared data: What leaders say is really driving payer-provider alignment
Recommended Whitepaper